CDTX
Price
$18.37
Change
-$0.00 (-0.00%)
Updated
Apr 3 closing price
Capitalization
195.19M
WINT
Price
$1.17
Change
-$0.06 (-4.88%)
Updated
Apr 4, 10:40 AM (EDT)
Capitalization
921.69K
Ad is loading...

CDTX vs WINT

Header iconCDTX vs WINT Comparison
Open Charts CDTX vs WINTBanner chart's image
Cidara Therapeutics
Price$18.37
Change-$0.00 (-0.00%)
Volume$9
Capitalization195.19M
Windtree Therapeutics
Price$1.17
Change-$0.06 (-4.88%)
Volume$1.12K
Capitalization921.69K
CDTX vs WINT Comparison Chart
Loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDTX vs. WINT commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a Hold and WINT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (CDTX: $18.37 vs. WINT: $1.23)
Brand notoriety: CDTX and WINT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 0% vs. WINT: 18%
Market capitalization -- CDTX: $195.19M vs. WINT: $921.69K
CDTX [@Biotechnology] is valued at $195.19M. WINT’s [@Biotechnology] market capitalization is $921.69K. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 0 FA rating(s) are green whileWINT’s FA Score has 1 green FA rating(s).

  • CDTX’s FA Score: 0 green, 5 red.
  • WINT’s FA Score: 1 green, 4 red.
According to our system of comparison, both CDTX and WINT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 4 TA indicator(s) are bullish while WINT’s TA Score has 5 bullish TA indicator(s).

  • CDTX’s TA Score: 4 bullish, 6 bearish.
  • WINT’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, WINT is a better buy in the short-term than CDTX.

Price Growth

CDTX (@Biotechnology) experienced а -14.87% price change this week, while WINT (@Biotechnology) price change was -25.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

CDTX is expected to report earnings on Aug 13, 2024.

WINT is expected to report earnings on May 17, 2023.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($195M) has a higher market cap than WINT($922K). CDTX YTD gains are higher at: -31.659 vs. WINT (-92.957). WINT has higher annual earnings (EBITDA): -9.36M vs. CDTX (-175.87M). CDTX has more cash in the bank: 190M vs. WINT (917K). WINT has less debt than CDTX: WINT (2.01M) vs CDTX (3.58M). CDTX has higher revenues than WINT: CDTX (1.28M) vs WINT (0).
CDTXWINTCDTX / WINT
Capitalization195M922K21,150%
EBITDA-175.87M-9.36M1,879%
Gain YTD-31.659-92.95734%
P/E RatioN/A0.83-
Revenue1.28M0-
Total Cash190M917K20,720%
Total Debt3.58M2.01M178%
FUNDAMENTALS RATINGS
CDTX vs WINT: Fundamental Ratings
CDTX
WINT
OUTLOOK RATING
1..100
7926
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
6198
P/E GROWTH RATING
1..100
1004
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CDTX's Valuation (47) in the Biotechnology industry is in the same range as WINT (62). This means that CDTX’s stock grew similarly to WINT’s over the last 12 months.

CDTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as WINT (100). This means that CDTX’s stock grew similarly to WINT’s over the last 12 months.

WINT's SMR Rating (99) in the Biotechnology industry is in the same range as CDTX (100). This means that WINT’s stock grew similarly to CDTX’s over the last 12 months.

CDTX's Price Growth Rating (61) in the Biotechnology industry is somewhat better than the same rating for WINT (98). This means that CDTX’s stock grew somewhat faster than WINT’s over the last 12 months.

WINT's P/E Growth Rating (4) in the Biotechnology industry is significantly better than the same rating for CDTX (100). This means that WINT’s stock grew significantly faster than CDTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDTXWINT
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 16 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 16 days ago
69%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
87%
Bullish Trend 23 days ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BEOIX8.37N/A
N/A
Barrow Hanley Concentrated EM ESG Opps I
HCMAX28.04N/A
N/A
Hillman Value No Load
HQIAX20.69N/A
N/A
Hartford Equity Income A
NCLEX28.49N/A
N/A
Nicholas Limited Edition I
MAEGX13.25N/A
N/A
BlackRock Unconstrained Equity Instl

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with BPTSY. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then BPTSY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
N/A
BPTSY - CDTX
92%
Closely correlated
N/A
IVVD - CDTX
36%
Loosely correlated
-5.03%
CPRX - CDTX
35%
Loosely correlated
-1.43%
CABA - CDTX
33%
Poorly correlated
-4.03%
TRAW - CDTX
30%
Poorly correlated
-6.03%
More